La FDA aprueba un nuevo tratamiento para la enfermedad de Alzheimer


BioGen‚Äôs ‚ÄúAduhelm‚ÄĚ is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The FDA granted the drug approval as a new clinical trial begins.

Fuente: Youtube